Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer

2 Aug 2023

Abstract excerpt

BACKGROUND: PAX1 gene methylation plays an important role in the development of cervical cancer. However, its prognostic value after radiotherapy for locally advanced cervical cancer is unknown, so this study aimed to investigate the value of PAX1 gene methylation for predicting the sensitivity of radiotherapy for cervical cancer. METHODS: We selected 125 patients with primary cervical cancer who underwent...

Topics

Join the communities discussing this publication.

Cancer-related gene regulation
Endometrial and Cervical Cancer Treatments
Epigenetics and DNA Methylation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37533109
DOI: 10.1186/s13148-023-01538-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancerPMID 37533109Read ↗

The promising role of PAX1 (aliases: HUP48, OFC2) gene methylation in cancer screeningSemantic proximity Read ↗

The research progress on radiation resistance of cervical cancerSemantic proximity Read ↗

Real time quantitative methylation detection of PAX1 gene in cervical cancer screeningSemantic proximity Read ↗

Novel marker genes and small molecule drugs for radiotherapy resistance in cervical cancer identified based on single-cell multi-omics analysisSemantic proximity Read ↗

A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screeningSemantic proximity Read ↗

Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells.Semantic proximity Read ↗

A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screeningSemantic proximity Read ↗

Signaling Pathways in Cervical Cancer Chemoresistance: Are microRNAs and Long-Noncoding RNAs the Main Culprits?Semantic proximity Read ↗

RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancerSemantic proximity Read ↗

LncRNA sequencing analysis of cervical cancer identifies radiotherapy sensitivity markersSemantic proximity Read ↗

Insights into the characteristics of primary radioresistant cervical cancer using single-cell transcriptomicsSemantic proximity Read ↗

DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of artSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.